Phase I clinical, biology & pharmacokinetic study of the combination of GW 572016 and capecitabine in patients with advanced solid tumors

被引：0
|
作者：
Schwartz, G
Chu, QSC
Hammond, LA
Mita, M
Curtright, J
Versola, MJ
Koch, K
Pandite, LN
Ho, PTC
Rowinsky, EK
机构：
[1] Brooke Army Med Ctr, San Antonio, TX USA
[2] Inst Drug Dev, San Antonio, TX USA
[3] GlaxoSmithKline, Res Triangle Pk, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3070
引用
收藏
页码：212S / 212S
页数：1
相关论文
共 50 条
  • [21] Phase I study of capecitabine and oxaliplatin in combination with the proteasome inhibitor bortezomib in patients with advanced solid tumors
    Cohen, Steven J.
    Engstrom, Paul F.
    Lewis, Nancy L.
    Langer, Corey J.
    McLaughlin, Susan
    Beard, Mary
    Weiner, Louis M.
    Meropol, Neal J.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2008, 31 (01): : 1 - 5
  • [22] A phase I study of vorinostat (VOR) in combination with capecitabine (CAP) in patients (pts) with advanced solid tumors
    Tang, P.
    Oza, A.
    Townsley, C.
    Siu, L.
    Pond, G.
    Sarveswaran, P.
    Webster, S.
    Zwiebel, J.
    Chen, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [23] A phase I and pharmacokinetic study of irofulven and capecitabine administered every 2 weeks in patients with advanced solid tumors
    Jérôme Alexandre
    Carmen Kahatt
    Frédérique Bertheault-Cvitkovic
    Sandrine Faivre
    Stephen Shibata
    Werner Hilgers
    François Goldwasser
    François Lokiec
    Eric Raymond
    Garry Weems
    Ajit Shah
    John R. MacDonald
    Esteban Cvitkovic
    Investigational New Drugs, 2007, 25 : 453 - 462
  • [24] A phase I and pharmacokinetic study of irofulven and capecitabine administered every 2 weeks in patients with advanced solid tumors
    Alexandre, Jerome
    Kahatt, Carmen
    Bertheault-Cvitkovic, Frederique
    Faivre, Sandrine
    Shibata, Stephen
    Hilgers, Werner
    Goldwasser, Francois
    Lokiec, Francois
    Raymond, Eric
    Weems, Garry
    Shah, Ajit
    MacDonald, John R.
    Cvitkovic, Esteban
    INVESTIGATIONAL NEW DRUGS, 2007, 25 (05) : 453 - 462
  • [25] A phase I clinical and pharmacokinetic study of oral CI-1033 in combination with docetaxel in patients with advanced solid tumors
    Garland, Linda L.
    Hidalgo, Manuel
    Mendelson, David S.
    Ryan, David P.
    Arun, Banu K.
    Lovalvo, Jennifer L.
    Eiseman, Irene A.
    Olson, Stephen C.
    Lenehan, Peter F.
    Eder, Joseph P.
    CLINICAL CANCER RESEARCH, 2006, 12 (14) : 4274 - 4282
  • [26] Phase I study of lapatinib (GW572016) in combination with letrozole in cancer patients
    Chu, Q.
    Rowinsky, E.
    Goldstein, L.
    Cianfrocca, M.
    Murray, N.
    Gale, M.
    Ho, P. T.
    Loftiss, J. I.
    Paul, E.
    Pandite, L.
    EJC SUPPLEMENTS, 2005, 3 (02): : 119 - 119
  • [27] A Phase I Study of Sunitinib Plus Capecitabine in Patients With Advanced Solid Tumors
    Sweeney, Christopher J.
    Chiorean, E. Gabriela
    Verschraegen, Claire F.
    Lee, Fa Chyi
    Jones, Suzanne
    Royce, Melanie
    Tye, Lesley
    Liau, Katherine F.
    Bello, Akintunde
    Chao, Richard
    Burris, Howard A.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (29) : 4513 - 4520
  • [28] A phase I study of gefitinib, capecitabine, and celecoxib in patients with advanced solid tumors
    Lam, Elaine T.
    O'Bryant, Cindy L.
    Basche, Michele
    Gustafson, Daniel L.
    Serkova, Natalie
    Baron, Anna
    Holden, Scott N.
    Dancey, Janet
    Eckhardt, S. Gail
    Gore, Lia
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (12) : 3685 - 3694
  • [29] A phase I clinical and pharmacokinetic study of ipifarnib in combination with docetaxel in patients with advanced solid malignancies
    Awada, Ahmad
    Zhang, Steven
    Gil, Thierry
    de Valeriola, Dominique
    Lalami, Yassine
    De Porre, Peter
    Piccart-Gebhart, Martine J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (05) : 991 - 1003
  • [30] Phase I and pharmacokinetic study of the multitargeted antifolate pemetrexed in combination with oxaliplatin in patients with advanced solid tumors
    Misset, JL
    Gamelin, E
    Campone, M
    Delaloge, S
    Latz, JE
    Bozec, L
    Fumoleau, P
    ANNALS OF ONCOLOGY, 2004, 15 (07) : 1123 - 1129
12345